Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
about
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.An integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesChronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in CaucasiansStudy of drug utilization pattern for acute exacerbation of chronic obstructive pulmonary disease in patients attending a government hospital in kerala, IndiaFunctional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD.COPD exacerbations.5: management.ABC of chronic obstructive pulmonary disease. Acute exacerbations.Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Comparison of Canadian versus United States emergency department visits for chronic obstructive pulmonary disease exacerbationPre-operative pulmonary assessment for patients with hip fracture.Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation.
P2860
Q33491797-3B34FE4D-BE7B-4620-AFFF-4ECE1173ADBFQ33766956-12C60469-2C05-4172-840C-6CA0225063E3Q34039712-0443D8D1-1A5C-485A-8EAE-004F0DAF93CAQ34075548-32DC9E60-6192-4F66-BD6B-56166E603F6CQ34405926-140EEC2A-F1FB-4C20-A4D0-D89919554BF5Q35596676-7F0E420F-31FD-4B3D-8FB4-8571A2421456Q36203144-5D246090-7A12-47F3-90AE-C61A66C97492Q36529415-36F23E79-26E5-4DE9-B0AC-9D660EDA57C8Q37029615-CE04FEBB-BD87-4601-A30F-A7FE1EF313C0Q37176055-C2FDD5A4-2E36-45C3-AAFD-8676F309CF73Q37177278-40847A74-DC77-4164-8220-9E08D525B44FQ37185508-3A6D9309-8DD6-4032-AF14-9E8772DDAC0DQ37807916-5F1E2382-E650-4349-B205-32A1380A70F3Q41951353-5E252E9E-F18D-4082-9B66-A6A8D9961606
P2860
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@ast
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en-gb
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@nl
type
label
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@ast
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en-gb
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@nl
prefLabel
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@ast
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en-gb
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@nl
P2860
P3181
P1476
Anticholinergic bronchodilator ...... obstructive pulmonary disease
@en
P2093
Cynthia D Brown
Douglas C McCrory
P2860
P3181
P356
10.1002/14651858.CD003900
P577
2003-01-20T00:00:00Z